Bafna Pharmaceuticals standalone net profit rises 19.08% in the September 2025 quarter
(12 Nov 2025)
Back
Net profit of Bafna Pharmaceuticals rose 19.08% to Rs 3.12 crore in the quarter ended September 2025 as against Rs 2.62 crore during the previous quarter ended September 2024. Sales declined 12.03% to Rs 35.47 crore in the quarter ended September 2025 as against Rs 40.32 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | | Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 35.47 | 40.32 | -12 |
| OPM % | 12.04 | 9.42 | - |
| PBDT | 4.59 | 4.20 | 9 |
| PBT | 3.12 | 2.62 | 19 |
| NP | 3.12 | 2.62 | 19 |
|